Algernon Pharmaceuticals's total assets for Q1 2026 were C$4.93M, an increase of 1.05% from the previous quarter. TSE:AGN total liabilities were C$2.44M for the fiscal quarter, a 11.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.